Skip to content

VR Embodiment for Stress Evaluation in a Return to Work Simulation

A Randomized Controlled Single Blind Parallel Study, Evaluating Embodiment in a VR Scenario Designed to Elicit Stress in a Return to Work E-vironment.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05379764
Acronym
VRSTEVAR
Enrollment
40
Registered
2022-05-18
Start date
2022-06-30
Completion date
2022-11-30
Last updated
2022-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burnout, Stress, Virtual Reality

Keywords

Virtual reality, stress, embodiment, Burnout

Brief summary

Comparing the emotional effect of two different versions of one VR experience. The VR experience will simulate a typical return to work situation after an absence due to burnout. The difference of the VR scenario is the point of view. In the first version, the 'standard' version, the user is looking at the VR experience from a neutral point of view, as if s/he was watching a 2D screen. In the second version, the 'embodiment' version, a VR features is added to have the user feeling incarnated in a digital human. This will enhance the feeling of being present in the virtual world and will enhance the emotional answer. The measured endpoint will be the evoked emotions, in particular stress.

Interventions

OTHEREmbodiment

Embodiment of a real human in a virtual human (avatar) means that the real human feels incarnated in the avatar. This happens when the real human sees the VRscenario from first person perspective, that the real human can make the avatar move (=agency over the avatar), multi-sensorial integration (=there is a link between the brain of the real human and the avatar. Example, when the avatar sits on a chair, the real human will too and he feels that he is sitting on a chair. Or when the avatar is moving the real human is doing the same movement (and of course the brain of the real human is aware of this movement)) and co-location (= avatar and real human have the sane posture).

OTHERObservation

The person is looking at the VR scenario as if s/he was looking at a TV

Sponsors

Universitair Ziekenhuis Brussel
CollaboratorOTHER
Clinique Saint-Jean, Bruxelles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

The principal investigator and outcome assessor will have no idea who is in what arm. It will be another investigator who is randomising the participant.

Intervention model description

Parallel single blind randomised controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* working in the office building where the study will be conducted

Exclusion criteria

* neurologic disorder precluding the use of VR goggles (epilepsy, …), * facial wounds precluding the use of VR goggles. * a preliminary test evaluating the stress level will be conducted, DASS -21: stress levels above moderate is an

Design outcomes

Primary

MeasureTime frameDescription
measured stress levelthis will be evaluated after the intervention and will take 15 min.This is measured with a Visual Analogue Scale from 1-10 and with the DASS-21, subscale stress

Secondary

MeasureTime frameDescription
measured Emotional level15 min, before (baseline) and after the interventiongeneral emotional level, measured with the PANAS scale
measured stress baseline15min, before the interventionThis is measured with a Visual Analogue Scale from 1-10 and with the DASS-21, subscale
embodiment evaluation20 min after the interventionmeasuring the level of embodiment experienced by the user
plausibility illusion and place illusion20 min after interventionAnswering the question: is it possible that it happens and that it happens here?. Assessed together with the level of embodiment, also with a questionnaire.

Contacts

Primary ContactArnaud Bosteels, MD
abosteels@clstjean.be02 221 97 62

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026